Calcineurin Is Required for Pseudohyphal Growth, Virulence, and Drug Resistance in Candida lusitaniae

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Zhang, Jing ^a,b   Silao, Fitz Gerald S ^c   Bigol, Ursela G ^d   Bungay, Alice Alma C ^c,e   Nicolas, Marilou G ^e   Heitman, Joseph ^a   Chen, Ying Lien ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c Dr Jose G Tamayo Medical University   (Philippines)

^d Environment and Biotechnology Division   (Philippines)

^e UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN INHIBITOR; CASPOFUNGIN; CYCLOSPORIN A; FLUCONAZOLE; KETOCONAZOLE; POSACONAZOLE; TACROLIMUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL RESISTANCE; ARTICLE; CALCIUM HOMEOSTASIS; CANDIDA ALBICANS; CELL WALL; CELLULAR STRESS RESPONSE; CLAVISPORA LUSITANIAE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOPLASMIC RETICULUM STRESS; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS ISOLATION; GENE SEQUENCE; KERATITIS; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIFUNGAL AGENTS; CALCINEURIN; CALCIUM; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CELL WALL; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; ENDOPLASMIC RETICULUM STRESS; FUNGAL PROTEINS; HOMEOSTASIS; HUMANS; HYPHAE; KERATITIS; KIDNEY; MICE; MICROBIAL SENSITIVITY TESTS; MODELS, BIOLOGICAL; MUTATION; SERUM; VIRULENCE;

CANDIDA; CANDIDA ALBICANS; CLAVISPORA LUSITANIAE; MURINAE;

EID: 84865626877     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044192     Document Type: Article

References (50)

1. Atkinson BJ, Lewis RE, Kontoyiannis DP, (2008) Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 46: 541-546.
2. Blinkhorn RJ, Adelstein D, Spagnuolo PJ, (1989) Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol 27: 236-240.
3. Hawkins JL, Baddour LM, (2003) Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis 36: e14-18.
4. Minari A, Hachem R, Raad I, (2001) Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin Infect Dis 32: 186-190.
5. Reedy JL, Floyd AM, Heitman J, (2009) Mechanistic plasticity of sexual reproduction and meiosis in the Candida pathogenic species complex. Curr Biol 19: 891-899.
6. Pappagianis D, Collins MS, Hector R, Remington J, (1979) Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother 16: 123-126.
7. Baker JG, Nadler HL, Forgacs P, Kurtz SR, (1984) Candida lusitaniae: a new opportunistic pathogen of the urinary tract. Diagn Microbiol Infect Dis 2: 145-149.
8. Desnos-Ollivier M, Moquet O, Chouaki T, Guerin AM, Dromer F, (2011) Development of echinocandin resistance in Clavispora lusitaniae during caspofungin treatment. J Clin Microbiol 49: 2304-2306.
9. Merz WG, (1984) Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 20: 1194-1195.
10. Pfaller MA, Diekema DJ, (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
11. Favel A, Michel-Nguyen A, Peyron F, Martin C, Thomachot L, et al. (2003) Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of the literature. Diagn Microbiol Infect Dis 47: 331-339.
12. Guinet R, Chanas J, Goullier A, Bonnefoy G, Ambroise-Thomas P, (1983) Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J Clin Microbiol 18: 443-444.
13. Young LY, Hull CM, Heitman J, (2003) Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother 47: 2717-2724.
14. Dutta A, Palazzi DL, (2011) Candida non-albicans versus Candida albicans fungemia in the non-neonatal pediatric population. Pediatr Infect Dis J 30: 664-668.
15. Chen YL, Brand A, Morrison EL, Silao FG, Bigol UG, et al. (2011) Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis. Eukaryot Cell 10: 803-819.
16. Chen YL, Konieczka JH, Springer DJ, Bowen SE, Zhang J, et al. (2012) Convergent evolution of calcineurin pathway roles in thermotolerance and virulence in Candida glabrata. G3 (Bethesda) 2: 675-691.
17. Cruz MC, Goldstein AL, Blankenship JR, Del Poeta M, Davis D, et al. (2002) Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21: 546-559.
18. Karababa M, Valentino E, Pardini G, Coste AT, Bille J, et al. (2006) CRZ1, a target of the calcineurin pathway in Candida albicans. Mol Microbiol 59: 1429-1451.
19. Zhang J, Heitman J, Chen YL, (2012) Comparative analysis of calcineurin signaling between Candida dubliniensis and Candida albicans. Commun Integr Biol 5: 122-126.
20. Steinbach WJ, Cramer RA Jr, Perfect BZ, Asfaw YG, Sauer TC, et al. (2006) Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus. Eukaryotic Cell 5: 1091-1103.
21. Cruz MC, Fox DS, Heitman J, (2001) Calcineurin is required for hyphal elongation during mating and haploid fruiting in Cryptococcus neoformans. EMBO J 20: 1020-1032.
22. Steinbach WJ, Reedy JL, Cramer RA Jr, Perfect JR, Heitman J, (2007) Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5: 418-430.
23. Chapeland-Leclerc F, Paccallet P, Ruprich-Robert G, Reboutier D, Chastin C, et al. (2007) Differential Involvement of Histidine Kinase Receptors in Pseudohyphal Development, Stress Adaptation, and Drug Sensitivity of the Opportunistic Yeast Candida lusitaniae. Eukaryotic Cell 6: 1782-1794.
24. Ruprich-Robert G, Chapeland-Leclerc F, Boisnard S, Florent M, Bories G, et al. (2008) Contributions of the response regulators Ssk1p and Skn7p in the pseudohyphal development, stress adaptation, and drug sensitivity of the opportunistic yeast Candida lusitaniae. Eukaryot Cell 7: 1071-1074.
25. Miller NS, Dick JD, Merz WG, (2006) Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar: association with amphotericin B resistance and filamentation. J Clin Microbiol 44: 1536-1539.
26. Blankenship JR, Wormley FL, Boyce MK, Schell WA, Filler SG, et al. (2003) Calcineurin is essential for Candida albicans survival in serum and virulence. Eukaryot Cell 2: 422-430.
27. Morris MI, Villmann M, (2006) Echinocandins in the management of invasive fungal infections, part 1. American Journal of Health-System Pharmacy 63: 1693-1703.
28. Butler G, Rasmussen MD, Lin MF, Santos MA, Sakthikumar S, et al. (2009) Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459: 657-662.
29. Tukmachev VA, Nedospasova LV, Zaslavsky BY, Rogozhin SV, (1979) Action of dodecyl-sulfate on biological membranes. Biofizika 24: 55-60.
30. Elorza MV, Rico H, Sentandreu R, (1983) Calcofluor white alters the assembly of chitin fibrils in Saccharomyces cerevisiae and Candida albicans cells. J Gen Microbiol 129: 1577-1582.
31. Roncero C, Durán A, (1985) Effect of Calcofluor white and Congo red on fungal cell wall morphogenesis: in vivo activation of chitin polymerization. Journal of Bacteriology 163: 1180-1185.
32. Boisnard S, Ruprich-Robert G, Florent M, Da Silva B, Chapeland-Leclerc F, et al. (2008) Insight into the role of HOG pathway components Ssk2p, Pbs2p, and Hog1p in the opportunistic yeast Candida lusitaniae. Eukaryot Cell 7: 2179-2183.
33. Boisnard S, Ruprich-Robert G, Florent M, Da Silva B, Chapeland-Leclerc F, et al. (2008) Role of Sho1p adaptor in the pseudohyphal development, drugs sensitivity, osmotolerance and oxidant stress adaptation in the opportunistic yeast Candida lusitaniae. Yeast 25: 849-859.
34. Young LY, Lorenz MC, Heitman J, (2000) A STE12 homolog is required for mating but dispensable for filamentation in Candida lusitaniae. Genetics 155: 17-29.
35. Onyewu C, Wormley FL Jr, Perfect JR, Heitman J, (2004) The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicans. Infect Immun 72: 7330-7333.
36. Chen YL, Kozubowski L, Cardenas ME, Heitman J, (2010) On the roles of calcineurin in fungal growth and pathogenesis. Curr Fungal Infect Rep 4: 244-255.
37. Sanglard D, Ischer F, Marchetti O, Entenza J, Bille J, (2003) Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48: 959-976.
38. Odom A, Muir S, Lim E, Toffaletti DL, Perfect J, et al. (1997) Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J 16: 2576-2589.
39. Choi JH, Kim Y, Lee Y-H, (2009) Functional analysis of MCNA, a gene encoding a catalytic subunit of calcineurin, in the rice blast fungus Magnaporthe oryzae. Journal of Microbiology and Biotechnology 19: 11-16.
40. Santos M, de Larrinoa IF, (2005) Functional characterization of the Candida albicans CRZ1 gene encoding a calcineurin-regulated transcription factor. Curr Genet 48: 88-100.
41. Blankenship JR, Heitman J, (2005) Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect Immun 73: 5767-5774.
42. Brand A, Shanks S, Duncan VM, Yang M, Mackenzie K, et al. (2007) Hyphal orientation of Candida albicans is regulated by a calcium-dependent mechanism. Curr Biol 17: 347-352.
43. Stokes C, Moran GP, Spiering MJ, Cole GT, Coleman DC, et al. (2007) Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans. Fungal Genet Biol 44: 920-931.
44. Parentin F, Liberali T, Perissutti P, (2006) Polymicrobial keratomycosis in a three-year-old child. Ocul Immunol Inflamm 14: 129-131.
45. Huynh N, Chang HY, Borboli-Gerogiannis S, (2012) Ocular involvement in hospitalized patients with candidemia: analysis at a Boston tertiary care center. Ocul Immunol Inflamm 20: 100-103.
46. Jackson BE, Wilhelmus KR, Mitchell BM, (2007) Genetically regulated filamentation contributes to Candida albicans virulence during corneal infection. Microb Pathog 42: 88-93.
47. Sewell DL, Pfaller MA, Barry AL, (1994) Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. Journal of Clinical Microbiology 32: 2099-2102.
48. Cantón E, Espinel-Ingroff A, Pemán J, (2009) Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Review of Anti-infective Therapy 7: 107-119.
49. Reuss O, Vik A, Kolter R, Morschhauser J, (2004) The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341: 119-127.
50. Gillum AM, Tsay EY, Kirsch DR, (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.